Reply to Trey Durdin, Alvin Goh, and Eugene Pietzak. Can an imaging-guided pathway replace the current paradigm for muscle-invasive bladder cancer?

BladderPath Trial Management Group

Research output: Contribution to journalComment/debatepeer-review

36 Downloads (Pure)

Search results